Author Question: If a long-term care facility does not participate in the Medicare and Medicaid program, federal ... (Read 51 times)

jilianpiloj

  • Hero Member
  • *****
  • Posts: 521
If a long-term care facility does not participate in the Medicare and Medicaid program, federal regulations still apply.
 
 Indicate whether the statement is true or false

Question 2

Distinguish between substantial compliance and substandard quality of care.



Perkypinki

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

FALSE

Answer to Question 2

Substantial compliance means that any deficiencies found by the surveyors are deemed to be of minimal potential of harm to the residents. Substandard quality of care means that the surveyors found one or more deficiencies that constitute either immediate jeopardy to resident health safety or a widespread potential for more than minimal harm but less than immediate jeopardy.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Oliver Wendell Holmes is credited with introducing the words "anesthesia" and "anesthetic" into the English language in 1846.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library